The umbilical cord: A rich and ethical stem cell source to advance regenerative medicine

Cell Proliferation

Volumn 44, Issue SUPPL. 1, 2011, Pages 60-69

  Forraz, N ^a   Mcguckin, C P ^a  

^a CTI LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ARTICLE; BLOOD STORAGE; CEREBRAL PALSY; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; EPIDERMOLYSIS BULLOSA; HUMAN; IMMUNOTHERAPY; INBORN ERROR OF METABOLISM; INSULIN DEPENDENT DIABETES MELLITUS; MEDICAL ETHICS; NEWBORN HYPOXIA; PLURIPOTENT STEM CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; SYSTEMIC LUPUS ERYTHEMATOSUS; UMBILICAL VEIN;

ANIMALS; FETAL BLOOD; HUMANS; REGENERATIVE MEDICINE; STEM CELL RESEARCH; STEM CELLS;

EID: 79953865882     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00729.x     Document Type: Article

References (92)

1. Haseltine WA (2001) The emergence of regenerative medicine: a new field and a new society. e-Biomed: J. Regen. Med. 2, 17-23.
2. Mironov V, Visconti RP, Markwald RR (2004) What is regenerative medicine? Emergence of applied stem cell and developmental biology. Expert Opin. Biol. Ther. 4, 773-781.
3. Greenwood HL, Thorsteinsdottir H, Perry G, Renihan J, Singer P, Daar A (2006) Regenerative medicine: new opportunities for developing countries. Int. J. Biotechnol. 8, 60-77.
4. Kaiser LR (1992) The future of multihospital systems. Top. Health Care Financ. 18, 32.
5. Nardo B, Masetti M, Urbani L, Caraceni P, Montalti R, Filipponi F, et al. (2004) Liver transplantation from donors aged 80years and over: pushing the limit. Am. J. Transplant. 4, 1139-1147.
6. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241-1246.
7. Macchiarini P, Jungebluth P et al. (2008) Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023-2030.
8. Bader A, Macchiarini P (2010) Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J. Cell. Mol. Med. 14, 1877-1889.
9. Mcguckin CP, Forraz N (2008) Umbilical cord blood stem cells - an ethical source for regenerative medicine. Med. Law 27, 147.
10. Maximow A (1909) Der Lymphozyt als gemeinsame Stammzelle der verschiedenen Bltelmente in der embryonalen Entwicklung und postfetalen Leben der Saugetiere. Folial. Haematol. 8, 125-141.
11. Till JCE, McCullo EA (1961) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat. Res. 14, 213-222.
12. Goodman JW, Hodgson GS (1962) Evidence for stem cells in the peripheral blood of mice. Blood 19, 702-714.
13. Thomas ED, Lochte HL, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 257, 491-496.
14. Cole RJ, Edwards RG, Paul J (1966) Cytodifferentiation and embryogenesis in cell colonies and tissue cultures derived from ova and blastocysts of the rabbit. Dev. Biol. 13, 385-407.
15. Thomson JA, Itskovitz-Eldor J et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
16. Lin G, Xu RH (2010) Progresses and challenges in optimization of human pluripotent stem cell culture. Curr. Stem Cell Res. Ther. 5, 207-214.
17. Codina M, Elser J, Margulies KB (2010) Current status of stem cell therapy in heart failure. Curr. Cardiol. Rep. 12, 199-208.
18. Bey E, Prat M et al. (2010) Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen. 18, 50-58.
19. Benderitter M, Gourmelon P et al. (2010) New emerging concepts in the medical management of local radiation injury. Health Phys. 98, 851-857.
20. Kolli S, Ahmad S, Lako M, Figueiredo F (2010) Successful clinical implementation of corneal epithelial stem cell therapy for treatment of unilateral limbal stem cell deficiency. Stem Cells 28, 597-610.
21. Uccelli A, Mancardi G (2010) Stem cell transplantation in multiple sclerosis. Curr. Opin. Neurol. 23, 218-225.
22. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV (1974) Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17, 331-340.
23. Dexter TM (1982) Is the marrow stroma transplantable? Nature 298, 222-223.
24. Deans RJ, Moseley AB (2000) Mesenchymal stem cells-Biology and potential clinical uses. Exp. Hematol. 28, 875-884.
25. Parekkadan B, Milwid JM (2010) Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87-117.
26. Bianco P, Gehron Robey P, Saggio I, Riminucci M (2010) "Mesenchymal" stem cells in human bone marrow (skeletal stem cells) - a critical discussion of their nature, identity, and significance in incurable skeletal disease. Hum. Gene Ther. 21, 1057-1066.
27. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
28. Zhou H, Ding S (2010) Evolution of induced pluripotent stem cell technology. Curr. Opin. Hematol. 17, 276-280.
29. Mcguckin CP, Forraz N (2008) Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif. 41(Suppl. 1), 31-40.
30. Mcguckin CP, Basford C, Hanger K, Habibollah S, Forraz N (2007) Cord blood revelations: the importance of being a first born girl, big, on time and to a young mother! Early Hum. Dev. 83, 733-741.
31. Wharton T (1656) Adenographia. London: Oxford Univ Pr.
32. Basford C, Forraz N, Hanger K, Habibollah S, Mcguckin CP (2010) The Cord Blood Separation League Table: a comparison of the major clinical grade harvesting techniques for Cord Blood Stem cells. Int. J. Stem Cells 3, 32-45.
33. Basford C, Forraz N, Mcguckin C (2010) Optimized multiparametric immunophenotyping of umbilical cord blood cells by flow cytometry. Nat. Protoc. 5, 1337-1346.
34. Basford C, Forraz N, Habibollah S, Hanger K, Mcguckin CP (2009) Umbilical cord blood processing using Prepacyte-CB increases haematopoietic progenitor cell availability over conventional Hetastarch separation. Cell Prolif. 42, 751-761.
35. Knudtzon S (1974) In vitro growth of granulocytic colonies from circulating cells in human cord blood. Blood 43, 357-361.
36. Broxmeyer HE, Douglas GW et al. (1989) Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86, 3828-3832.
37. Forraz N, Pettengell R, Deglesne PA, Mcguckin CP (2002) AC133+ umbilical cord blood progenitors demonstrate rapid self-renewal and low apoptosis. Br. J. Haematol. 119, 516-524.
38. Forraz N, Pettengell R, Mcguckin CP (2004) Characterization of a lineage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells 22, 100-108.
39. Mcguckin CP, Forraz N, Pettengell R, Thompson A (2004) Thrombopoietin, flt3-ligand and c-kit-ligand modulate HOX gene expression in expanding cord blood CD133 cells. Cell Prolif. 37, 295-306.
40. Mcguckin CP, Pearce D, Forraz N, Tooze JA, Watt SM, Pettengell R (2003) Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur. J. Haematol. 71, 341-350.
41. Mcguckin CP, Forraz N et al. (2003) Colocalization analysis of sialomucins CD34 and CD164. Stem Cells 21, 162-170.
42. Forraz N, Pettengell R, Mcguckin CP (2002) Haemopoietic and neuroglial progenitors are promoted during cord blood ex vivo expansion. Br. J. Haematol. 119, 888.
43. Mcguckin CP, Forraz N, Allouard Q, Pettengell R (2004) Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Exp. Cell Res. 295, 350-359.
44. Mcguckin CP, Forraz N et al. (2005) Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif. 38, 245-255.
45. Mcguckin C, Forraz N et al. (2006) Embryonic-like stem cells from umbilical cord blood and potential for neural modeling. Acta Neurobiol. Exp. (Wars) 66, 321-329.
46. Denner L, Bodenburg Y et al. (2007) Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif. 40, 367-380.
47. Mcguckin C, Jurga M, Ali H, Strbad M, Forraz N (2008) Culture of embryonic-like stem cells from human umbilical cord blood and onward differentiation to neural cells in vitro. Nat. Protoc. 3, 1046-1055.
48. Mcguckin CP, Forraz N (2008) Cord blood stem cells-potentials and realities. In: Polak J, Mantalaris S, Harding SE, eds. Advances in Tissue Engineering, pp. 123-142. London: Imperial College Press.
49. Howe M, Zhao J et al. (2009) Oct-4A isoform is expressed in human cord blood-derived CD133 stem cells and differentiated progeny. Cell Prolif. 42, 265-275.
50. Ali H, Jurga M, Kurgonaite K, Forraz N, Mcguckin C (2009) Defined serum-free culturing conditions for neural tissue engineering of human cord blood stem cells. Acta Neurobiol. Exp. (Wars) 69, 12-23.
51. Kucia M, Halasa M et al. (2007) Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 21, 297-303.
52. Harris DT, Rogers I (2007) Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. Curr. Stem Cell Res. Ther. 2, 301-309.
53. Halasa M, Baskiewicz-Masiuk M, Dabkowska E, Machalinski B (2008) An efficient two-step method to purify very small embryonic-like (VSEL) stem cells from umbilical cord blood (UCB). Folia Histochem. Cytobiol. 46, 239-243.
54. Moon YJ, Lee MW et al. (2008) Hepatic differentiation of cord blood-derived multipotent progenitor cells (MPCs) in vitro. Cell Biol. Int. 32, 1293-1301.
55. Leeb C, Jurga M, Mcguckin C, Moriggl R, Kenner L (2010) Promising new sources for pluripotent stem cells. Stem Cell Rev. 6, 15-26.
56. Forraz N, Baradez MO, Mcguckin CP (2006) Characterization of the first umbilical cord blood multi lineage progenitor cell (TM) line by high definition microarray. Tissue Eng. 12, 1055.
57. Erices A, Conget P, Minguell JJ (2000) Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109, 235-242.
58. Shetty P, Cooper K, Viswanathan C (2010) Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J. Transfus. Sci. 4, 14-24.
59. Harris DT (2009) Non-haematological uses of cord blood stem cells. Br. J. Haematol. 147, 177-184.
60. McElreavey KD, Irvine AI, Ennis KT, McLean WH (1991) Isolation, culture and characterisation of fibroblast-like cells derived from the Wharton's jelly portion of human umbilical cord. Biochem. Soc. Trans. 19, 29S.
61. Zeddou M, Briquet A et al. (2010) The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol. Int. 34, 693-701.
62. Xu HH, Zhao L, Detamore MS, Takagi S, Chow LC (2010) Umbilical cord stem cell seeding on fast-resorbable calcium phosphate bone cement. Tissue Eng. Part A 16, 2743-2753.
63. Caballero M, Reed CR, Madan G, van Aalst JA (2010) Osteoinduction in umbilical cord- and palate periosteum-derived mesenchymal stem cells. Ann. Plast. Surg. 64, 605-609.
64. Schneider RK, Püllen A et al. (2010) Long-term survival and characterisation of human umbilical cord-derived mesenchymal stem cells on dermal equivalents. Differentiation 79, 182-193.
65. Alaminos M, Pérez-Köhler B et al. (2010) Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells. J. Cell. Physiol. 223, 640-647.
66. Zhang YN, Lie PC, Wei X (2009) Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Cytotherapy 11, 548-558.
67. Anzalone R, Iacono ML et al. (2010) New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev. 19, 423-438.
68. Zhang HT, Fan J et al. (2010) Human Wharton's jelly cells can be induced to differentiate into growth factor-secreting oligodendrocyte progenitor-like cells. Differentiation 79, 15-20.
69. Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB (2010) Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5, e9016.
70. Crampton SP, Davis J, Hughes CC (2007) Isolation of human umbilical vein endothelial cells (HUVEC). J. Vis. Exp. 183, 1-11.
71. Yamaguchi H, Ishii E, Tashiro K, Miyazaki S (1998) Role of umbilical vein endothelial cells in hematopoiesis. Leuk. Lymphoma 31, 61-69.
72. Kægler G, Wernet P (2006) Pluripotent stem cells from umbilical cord blood. In: Ho AD, Hoffman R, Zanjani ED, eds. Stem Cell Transplantation: Biology, Processing, and Therapy, pp. 73-85. Wiley VCH: Weinheim. ISBN-10: 3-527-31018-5.
73. Covas DT, Panepucci RA et al. (2008) Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol. 36, 642-654.
74. Corselli M, Chen CW, Crisan M, Lazzari L, Péault B (2010) Perivascular ancestors of adult multipotent stem cells. Arterioscler. Thromb. Vasc. Biol. 30, 1104-1109.
75. Halbrecht J (1939) Transfusion with placental blood. Lancet 263, 202-203.
76. Halbrecht J (1939) Fresh and stored placental blood. Lancet 264, 1263-1265.
77. Ende M, Ende N (1972) Hematopoietic transplantation by means of fetal (cord) blood. Va. Med. Mon. 99, 276-280.
78. Gluckman E, Broxmeyer HA et al. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174-1178.
79. Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E (1995) Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet 346, 214-219.
80. Kurtzberg J, Graham M, Casey J, Olson J, Stevens CE, Rubinstein P (1994) The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 20, 275-283; discussion 284.
81. Escalón MP, Komanduri KV (2010) Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution. Curr. Opin. Oncol. 22, 122-129.
82. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID (2010) Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med. 16, 232-236.
83. Gluckman E (2009) History of cord blood transplantation. Bone Marrow Transplant. 44, 621-626.
84. Ferreira E, Pasternak J, Bacal N, de Campos Guerra JC, Mitie Watanabe F (1999) Autologous cord blood transplantation. Bone Marrow Transplant. 24, 104.
85. Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN (2007) First report of autologous cord blood transplantation in the treatment of a child with leukaemia. Pediatrics 119, e296-e300.
86. Thornley I, Eapen M, Sung L, Lee SJ, Davies SM, Joffe S (2009) Private cord blood banking: experiences and views of pediatric hematopoietic cell transplantation physicians. Pediatrics 123, 1011-1017.
87. Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA (2008) Autologous umbilical cord blood infusion for type 1 diabetes. Exp. Hematol. 36, 710-715.
88. Haller MJ, Wasserfall CH et al. (2009) Autologous umbilical cord blood transfusion in very young children with type 1 diabetes. Diabetes Care 32, 2041-2046.
89. Reddi AS, Kuppasani K, Ende N (2010) Human umbilical cord blood as an emerging stem cell therapy for diabetes mellitus. Curr. Stem Cell Res. Ther. 5, 356-361.
90. Sun L, Wang D, Liang J, Zhang H, Feng X, Wang H et al. (2010) Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62, 2467-2475.
91. Tolar J, Ishida-Yamamoto A et al. (2009) Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113, 1167-1174.
92. Prasad VK, Kurtzberg J (2010) Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions. Br. J. Haematol. 148, 356-372.